How to manage Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Diabetic Ketoacidosis (DKA)

The management of DKA requires immediate fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour during the first hour, followed by continuous intravenous regular insulin infusion at 0.1 units/kg/hour without an initial bolus, while closely monitoring electrolytes, particularly potassium. 1, 2

Initial Assessment and Diagnosis

  • Diagnostic criteria for DKA include: blood glucose >250 mg/dL, arterial pH <7.3, serum bicarbonate <15 mEq/L, and presence of ketonemia or ketonuria 1
  • Laboratory evaluation should include plasma glucose, blood urea nitrogen/creatinine, serum ketones, electrolytes (with calculated anion gap), osmolality, urinalysis, urine ketones, arterial blood gases, complete blood count with differential, and electrocardiogram 1, 2
  • Obtain bacterial cultures (urine, blood, throat) if infection is suspected and administer appropriate antibiotics 2
  • Identify potential precipitating factors: infection, cerebrovascular accident, alcohol abuse, pancreatitis, myocardial infarction, trauma, drugs, or insulin discontinuation/inadequacy 1

Treatment Protocol

Fluid Therapy

  • Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour (approximately 1-1.5 L in the average adult) during the first hour 1, 2
  • Subsequent fluid choice depends on hydration status, serum electrolyte levels, and urine output 1
  • When serum glucose reaches 250 mg/dL, change fluid to 5% dextrose with 0.45-0.75% NaCl to prevent hypoglycemia while continuing insulin therapy 1
  • Total fluid replacement should aim to correct estimated deficits within 24 hours 2

Insulin Therapy

  • Start with continuous intravenous regular insulin infusion at 0.1 units/kg/hour (preferred method for moderate to severe DKA) without an initial bolus 1, 2
  • If plasma glucose does not fall by 50 mg/dL from initial value in the first hour, check hydration status; if acceptable, double the insulin infusion rate every hour until a steady glucose decline of 50-75 mg/h is achieved 1
  • Continue insulin infusion until resolution of ketoacidosis (pH >7.3, serum bicarbonate ≥18 mEq/L, and anion gap ≤12 mEq/L) regardless of glucose levels 1, 2
  • When serum glucose reaches 250 mg/dL, decrease insulin infusion to 0.05-0.1 units/kg/hour and add dextrose to IV fluids 2

Electrolyte Management

  • Include 20-30 mEq/L potassium (2/3 KCl and 1/3 KPO₄) in the infusion once renal function is assured and serum potassium is <5.3 mEq/L 1, 2
  • Monitor potassium levels closely, as insulin administration can cause hypokalemia; maintain serum K⁺ between 4-5 mmol/L 1, 2
  • In patients with relatively low plasma potassium levels, temporarily delay insulin administration and first administer potassium chloride intravenously to bring plasma potassium close to 4 mmol/L 3
  • Bicarbonate administration is generally not recommended for DKA patients with pH >6.9 2

Monitoring During Treatment

  • Check blood glucose every 1-2 hours 2
  • Draw blood every 2-4 hours to determine serum electrolytes, glucose, blood urea nitrogen, creatinine, osmolality, and venous pH 1, 2
  • Follow venous pH (typically 0.03 units lower than arterial pH) and anion gap to monitor resolution of acidosis 1
  • Direct measurement of β-hydroxybutyrate in blood is the preferred method for monitoring DKA, as the nitroprusside method only measures acetoacetic acid and acetone 1

Resolution Parameters and Transition to Subcutaneous Insulin

  • DKA resolution requires: glucose <200 mg/dL, serum bicarbonate ≥18 mEq/L, venous pH >7.3, and anion gap ≤12 mEq/L 1, 2
  • When DKA resolves and the patient can eat, start a multiple-dose insulin schedule using a combination of short/rapid-acting and intermediate/long-acting insulin 1, 2
  • Administer basal insulin 2-4 hours before stopping the IV insulin infusion to prevent recurrence of ketoacidosis 2

Common Pitfalls to Avoid

  • Premature termination of insulin therapy before complete resolution of ketosis can lead to recurrence of DKA 1, 2
  • Interruption of insulin infusion when glucose levels fall without adding dextrose is a common cause of persistent or worsening ketoacidosis 1, 2
  • Failure to add dextrose when glucose falls below 250 mg/dL while continuing insulin therapy 1
  • Inadequate monitoring and replacement of electrolytes, particularly potassium 1, 2
  • Overzealous fluid resuscitation and rapid correction of hyperglycemia may contribute to cerebral edema, particularly in children 4
  • Relying on nitroprusside method to measure ketones is misleading as it only measures acetoacetic acid and acetone, not β-hydroxybutyrate 2

References

Guideline

Assessment and Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Approach to the Treatment of Diabetic Ketoacidosis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.